Two King’s Awards have been presented to SureScreen Diagnostics, one for Innovation and another for International Trade.
SureScreen obtained the honours for its recent efforts, which included developing, producing, and exporting millions of pioneering and cutting-edge lateral flow tests for the UK and healthcare organisations across 60 other nations.
Their Covid 19 tests were also the first ones made in Europe to be cleared by Public Health England. Therefore, becoming a crucial component of the UK administrations’ testing effort and being exported to aid other nations in their fight against Covid 19.
SureScreen Diagnostics’ Director, David Campbell, expressed that the “company has been built on scientific innovation and has always exported a significant volume of our products, so these awards reflect” their core values.
Over the pandemic period, they created “a strong platform to help millions of people by giving them the ability to take control of their health and diagnose issues early”
Since its establishment back in 1996, Surescreen has been producing lateral flow tests, including those for drug detection, fertility screening, and more recently Flu and Strep A, among others.
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.